K
Keith M. Sullivan
Researcher at Duke University
Publications - 458
Citations - 40788
Keith M. Sullivan is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 105, co-authored 447 publications receiving 39067 citations. Previous affiliations of Keith M. Sullivan include American Cancer Society & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis
Julia Z. Adamska,Amin Zia,Michelle S. Bloom,Leslie J. Crofford,Daniel E. Furst,Ellen Goldmuntz,Lynette Keyes-Elstein,Maureen D. Mayes,Peter A. McSweeney,J. A. Nash,Ashley Pinckney,Beverly Welch,Zelda Z Love,Keith M. Sullivan,William H. Robinson +14 more
TL;DR: Findings suggest that myeloablative autologous HSCT resets the IGH repertoire to a more naïve state characterised by IgM-expressing B cells, providing a possible mechanism for the elimination of pathogenic B cells that may contribute to the benefit of HSCT over CYC in the treatment of dcSSc.
Journal ArticleDOI
Denials Of Treatment Coverage By Health Insurance Carriers Restrict Patient Recruitment On A Randomized Clinical Trial: Experience Of 95 Patients With Systemic Sclerosis (SSc) Enrolled In The SCOT (Scleroderma: Cyclophosphamide Or Transplantation) Trial
Keith M. Sullivan,James R. Seibold,Shin Mineishi,Maureen D. Mayes,Chitra Hosing,Richard A. Nash,Mark H. Wener,Mary Ellen Csuka,Christopher Bredeson,Robert W. Simms,Karen K. Ballen,S.J. Forman,W. St. Clair,Daniel E. Furst +13 more
Journal ArticleDOI
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis
William A. Wood,Ruta Brazauskas,Zhen-Huan Hu,Hisham Abdel-Azim,Ibrahim Ahmed,Mahmoud Aljurf,Sherif M. Badawy,Amer Beitinjaneh,Biju George,David Buchbinder,Jan Cerny,Laurence Dedeken,Miguel Angel Diaz,Cesar O. Freytes,Siddhartha Ganguly,Usama Gergis,David Gómez Almaguer,Ashish Gupta,Gregory A. Hale,Shahrukh K. Hashmi,Shahrukh K. Hashmi,Yoshihiro Inamoto,Rammurti T. Kamble,Kehinde Adekola,Tamila L. Kindwall-Keller,Jennifer M. Knight,Lalit Kumar,Yachiyo Kuwatsuka,Jason Law,Hillard M. Lazarus,Charles F. LeMaistre,Richard F. Olsson,Richard F. Olsson,Michael A. Pulsipher,Bipin N. Savani,Kirk R. Schultz,Ayman Saad,Matthew D. Seftel,Sachiko Seo,Thomas C. Shea,Amir Steinberg,Keith M. Sullivan,David Szwajcer,Baldeep Wirk,Jean A. Yared,Agnes S. M. Yong,Jignesh Dalal,Theresa Hahn,Nandita Khera,Carmem Bonfim,Yoshiko Atsuta,Wael Saber +51 more
TL;DR: Country-level macroeconomic indices were associated with lower survival at 100 days after alloHCT for ALL, and transplants performed within lower resourced environments wereassociated with inferior overall survival.